EUCAST News
Here you can find the latest news and updates from EUCAST.
Guidance on the reporting of susceptibility in endocarditis pathogens
With the 2025 (v 15.0) breakpoint table (for formal release on the 1st of January) EUCAST has released guidance on the reporting of susceptibility test results on endocarditis pathogensto help explain how to use the...[more]
Breakpoint table v 15.0 released for consultation
The breakpoint table v 15.0 available for consultation (5 - 16 Dec, 2024). The finalised table will be published on 1 January, 2025. [more]
The breakpoint table for antifungal agents and the presentation of ECOFFs updated.
The breakpoint table for antifungal agents(V. 11) and the overview of clinical breakpoints and ECOFFs have been updated. [more]
Anidulafungin and micafungin rationale documents updated
The anidulafungin and micafungin rationale documents updated by the EUCAST AFST subcommittee (25 November, 2024). [more]
Public consultation on Endocarditis breakpoints - EUCAST response
Following public consultation, EUCAST publishes formal responses to queries and views submitted during the consultation period. The comments during the consultation on EUCAST proposed endocarditis breakpoints, the EUCAST...[more]
Guidance on Stenotrophomonas maltophilia - updated November, 2024.
The EUCAST guidance on the use of antimicrobial agents in Stenotrophomonas maltophilia. [more]
When there are no breakpoints!
The first and very important question is, when are there no breakpoints in the EUCAST breakpoint tables? Look for guidance on the interpretation of test results in breakpoint tables, expert rules and in EUCAST advice on...[more]
